Revenio Group Corporation: Sales permit for Icare TA01i tonometer granted in Brazil

Revenio Group Corporation Stock Exchange Release 19 March 2015 at 14:00

Sales permit for Icare TA01i tonometer granted in Brazil

The Brazilian Health Surveillance Agency ANVISA has granted a sales permit to
TA01i tonometer made by Icare Finland Oy, which is part of Revenio Group. The
sales permit is expected to pave the way to a significant market for Icare in
Brazil in the coming years. Icare has also applied for a sales permit for their
HOME tonometer for patients who monitor their eye pressures themselves as part
of their treatment process.

Following this decision in Brazil, Icare has a sales permit for its TA01i
tonometer in all key countries.

Revenio Group Corporation
Olli-Pekka Salovaara
CEO

For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

Distribution:
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business lies in tonometers.
The Revenio Health Tech segment comprises the business operations of Icare
Finland Oy and Oscare Medical Oy, which specializes in osteoporosis screening
and monitoring. In addition, Revenio has identified new growth opportunities
relating to health tech in which common denominators are screening, follow-up
and the global need to make cost savings in health care through preventive
measures. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating
margin for continuing operations standing at 27.5%. Revenio Group Corporation
has been listed in Nasdaq Helsinki.

[HUG#1904447]